Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and axonal degeneration. MS patients typically present with a relapsing-remitting (RR) disease course, manifesting as sporadic attacks of neurological symptoms including ataxia, fatigue, and sensory impairment. While there are several effective disease-modifying therapies able to address the inflammatory relapses associated with RRMS,

Stem Cell Therapy can be easily classified according to the source of the stem cells used. In modest words, a stem cell is the pioneer cell in the body that has the capability to develop into various kinds of body cells such as blood cells, skin cells, etc. Each cell has the potential either to remain a stem cell or turn into another kind of cell with a more particular role,

Regenerative Medicine is a Medical Field that focuses on regrowing, repairing and restoring damaged tissue, organs or cells. Part of Regenerative Medicine is the use of Stem Cells as a therapy for different illnesses or conditions. Stem Cells are able to transform into other human cells in the body, the purpose of cellular therapy is to repair damaged tissue,

ProgenCell – Stem Cell Therapies is announcing the launch of an updated Stem Cell Treatment Protocol for neurological conditions (such as Parkinson’s Disease, Alzheimer’s, Multiple Sclerosis and Amyotrophic Lateral Sclerosis). The stem cell therapy protocol has been done with autologous transplantation of bone marrow derived stem cells, delivered intrathecally and intravenously. The protocol is composed of a regimen of intravenous infusions of vitamins,